Breaking News

Detection of melanoma-associated antigens for molecular staging: Results of a 5-year study

Detection of melanoma-associated antigens for molecular staging: Results of a 5-year study

 
 

The prognostic impact of five melanoma markers (Melan-A, gp100, MAGE-3, MIA and tyrosinase) was evaluated by multimarker real-time polymerase chain reaction (RT-PCR) for disease-specific survival time. Data from 65 patients with resected melanoma (stage II-III) were assessed. Blood samples were examined every 3 months for 2 years. Expression of melanoma markers was correlated with clinical staging results for 5 years. MAGE-3 was the most sensitive marker in single occurrence or combined with MIA and gp100. Progression in the first, second, third, fourth and fifth years was seen in 40.7, 25.9, 18.6, 7.4 and 7.4%, respectively. Statistically significant marker elevation during the first 2 years after surgery correlated with a worse prognosis. Thus ...

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to breaking news list